Skip to main content
    I

    Ionis Pharmaceuticals Inc (IONS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $28.01
    -1.05 (-3.61%)

    Market Cap: $4.84B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ionis Pharmaceuticals Inc (IONS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Ionis Pharmaceuticals (IONS) trades at 4.8x sales and 11.8x book value. Its P/S of 4.8x is below its 5-year median of 8.2x. Its forward P/E is 90.9x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E90.9x
    Price to sales4.8x
    Price to book11.8x
    PEGN/A
    FCF yield-13.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 48.4% below 9.3x and its P/B is 18.0% above 10.0x.

    MultipleCurrent5-year median10-year median
    P/S4.8x8.2x9.3x
    P/B11.8x11.6x10.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 5.7x in 2021 to 15.7x in 2016.

    Year endPriceP/EP/SP/B
    2025$79.11N/A13.4x26.2x
    2024$34.96N/A7.4x9.4x
    2023$50.59N/A9.3x24.8x
    2022$37.77N/A9.1x9.4x
    2021$30.4362.1x5.7x6.3x
    2020$56.54N/A10.8x9.4x
    2019$60.4127.5x7.8x6.3x
    2018$54.06N/A12.3x7.7x
    2017$50.30N/A12.2x19.3x
    2016$47.83N/A15.7x59.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IONS

    What is IONS's forward P/E ratio?

    Ionis Pharmaceuticals has a forward P/E ratio of 90.9x.

    Is IONS stock overvalued?

    GNG's valuation label for IONS is Undervalued.

    What is IONS's price to sales ratio?

    Ionis Pharmaceuticals has a price to sales ratio of 4.8x.